Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial

Published:2023-07 Issue:7 Volume:11 Page:613-623
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Tang Rong,Zheng Hui,Wang Bu-Sen,Gou Jin-Bo,Guo Xi-Ling,Chen Xiao-Qin,Chen Yin,Wu Shi-Po,Zhong Jin,Pan Hong-Xing,Zhu Jia-Hong,Xu Xiao-Yu,Shi Feng-Juan,Li Zhuo-Pei,Liu Jing-Xian,Zhang Xiao-Yin,Cui Lun-Biao,Song Zhi-Zhou,Hou Li-Hua,Zhu Feng-Cai,Li Jing-Xin,Huang Hai-Tao,Li Xiao-Long,Wang Xue,Wan Peng,Zhu Tao

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference24 articles.

1. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression;Feikin;Lancet,2022

2. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant;Andrews;N Engl J Med,2022

3. Neutralization of SARS-CoV-2 omicron by BNT162b2 mRNA vaccine-elicited human sera;Muik;Science,2022

4. Effect of mRNA vaccine boosters against SARS-CoV-2 omicron infection in Qatar;Abu-Raddad;N Engl J Med,2022

5. Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 omicron and delta variants;Servellita;Cell,2022

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune responses and transcription landscape of adults with the third dose of homologous and heterologous booster vaccines of COVID-19;Frontiers in Immunology;2024-09-12

2. Vaccines for Respiratory Viruses—COVID and Beyond;Vaccines;2024-08-22

3. Molecular basis of Ad5-nCoV Vaccine-Induced Immunogenicity;2024-06-21

4. Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study;Emerging Microbes & Infections;2024-04-28

5. Safety, immunogenicity, and protective effective of inhaled COVID‐19 vaccines: A systematic review and meta‐analysis;Journal of Medical Virology;2024-04